Business

Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent

PARIS, May 05, 2026--Jeito Capital ("Jeito"), a leading global independent private equity fund dedicated to Biopharma, today announces the appointments of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent.

articleBiogen Inc.May 5, 20265/company/biogen-inc/news/jeito-capital-bolsters-its-leadership-team-with-the-appointment-of-elaine-caughey-mba-as-partner-business-development-and-investor-relations-and-sarah-shackelton-mpa-as-partner-talent
Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent

About this update from Biogen Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/da3596aa2c69a62a1cd24176da554f39"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oDaVbVMo1XsTPm0uK_kUuw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/da3596aa2c69a62a1cd24176da554f39","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/sY6iJZCSTrWOpaukwtdOsQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/da3596aa2c69a62a1cd24176da554f39","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Highly experienced partners bringing 25+ years of leadership across top-tier life-sciences investment fund, pharma and Biopharma companies, driving accelerated portfolio development","length":181,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":181,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"With leadership experience at Blackstone Life Sciences (Deputy Chief Operating Officer), Biogen, (NASDAQ: BIIB), and public and private Biopharma companies (including Kymera Therapeutics (NASDAQ: KYMR) and Cygnal Therapeutics), Elaine Caughey will support portfolio companies in strengthening operational execution, defining robust market access pathways, and enhancing their strategic value through business development support, including partnerships and acquisition transactions. She will also draw on her knowledge of the investment ecosystem to strengthen relationships with investors for both Jeito funds and its portfolio companies","length":638,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":638,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Sarah brings deep strategic expertise from senior roles at leading Biopharma investment firms - including as Partner, Marketing and Talent at Abingworth and as Chief Talent Officer at Oxford Science Enterprises - and top executive search firms including Coulter Partners and Spencer Stuart. She will focus on building exceptional senior leadership teams and boards across Jeito and its portfolio, attracting the high calibre talent that powers company acceler...

More updates from Biogen Inc.

Sarah ShackeltonElaine CaugheyBusiness Developmentportfolio companyInvestor Relationsprivate equity fundJeito CapitalSarahBiopharmaElaineinvestment